ArticleBlood cancer discovery2022

Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia.

Michael A Pulsipher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.